World's Best Scientists 2026 revealed!
Oscar S. Gershanik

Oscar S. Gershanik

D-Index & Metrics

Neuroscience

D-Index
41
Citations
7359
World Ranking
7825
National Ranking
17

Overview

Oscar S. Gershanik is affiliated with Favaloro University in Argentina, contributing extensively to the fields of medicine and neuroscience. Their research predominantly focuses on neurology, particularly addressing neurological disorders and treatments, with a significant emphasis on Parkinson's disease mechanisms and treatments. Additional subfields include cellular and molecular neuroscience, cognitive neuroscience, endocrinology, diabetes and metabolism, and molecular biology.

Their recent scholarly output includes publications in various reputable venues. Notable papers include:

  • "Six Action Steps to Address Global Disparities in Parkinson Disease," 2022, JAMA Neurology
  • "A Statement of the MDS on Biological Definition, Staging, and Classification of Parkinson's Disease," 2023, Movement Disorders
  • "Fyn Knock-Down Prevents Levodopa-Induced Dyskinesia in a Mouse Model of Parkinson's Disease," 2021, eNeuro
  • "Six Action Steps to Address Global Disparities in Parkinson Disease: A World Health Organization (WHO) Priority," 2022, SSRN Electronic Journal
  • "Unanswered Questions in Clinical Practice," 2023, Movement Disorders Clinical Practice

Frequent co-authors in their work include:

  • Michael S. Okun
  • Bastiaan R. Bloem
  • Victor S.C. Fung
  • Shen-Yang Lim
  • Njideka Okubadejo

Oscar S. Gershanik's publications are frequently found in these scientific journals and venues:

  • JAMA Neurology
  • Movement Disorders
  • eNeuro
  • SSRN Electronic Journal
  • Movement Disorders Clinical Practice

The scientist's main research topics focus on:

  • Neurological disorders and treatments
  • Parkinson's Disease Mechanisms and Treatments
  • Autism Spectrum Disorder Research
  • Neurological diseases and metabolism
  • Nuclear Receptors and Signaling
  • Genetic Neurodegenerative Diseases
  • Autoimmune Neurological Disorders and Treatments

Best Publications

  • Mice lacking dopamine D4 receptors are supersensitive to ethanol, cocaine, and methamphetamine

    Marcelo Rubinstein;Tamara J. Phillips;Tamara J. Phillips;James R. Bunzow;Tomás L. Falzone

  • Postural deformities in Parkinson's disease

    Karen M Doherty;Bart P van de Warrenburg;Maria Cecilia Peralta;Laura Silveira-Moriyama

  • Levodopa in the treatment of Parkinson's disease: current controversies.

    C. Warren Olanow;Yves Agid;Yoshi Mizuno;Alberto Albanese

  • Early Treatment of Parkinson’s Disease with Cabergoline Delays the Onset of Motor Complications

    U. K. Rinne;F. Bracco;C. Chouza;E. Dupont

  • Chronic levodopa is not toxic for remaining dopamine neurons, but instead promotes their recovery, in rats with moderate nigrostriatal lesions

    M G Murer;G Dziewczapolski;L B Menalled;M C García

  • Levodopa-induced dyskinesias in Parkinson's disease: clinical and pharmacological classification.

    M. R. Luquin;O. Scipioni;J. Vaamonde;O. Gershanik

  • Expanded and independent validation of the Movement Disorder Society–Unified Parkinson’s Disease Rating Scale (MDS-UPDRS)

    Pablo Martinez-Martin;Carmen Rodriguez-Blazquez;Mario Alvarez-Sanchez;Tomoko Arakaki

  • Behavioral correlations of dopamine receptor activation

    Oscar Gershanik;Richard E. Heikkila;Roger C. Duvoisin

  • The long-acting dopamine receptor agonist cabergoline in early Parkinson's disease: final results of a 5-year, double-blind, levodopa-controlled study.

    Fulvio Bracco;Angelo Battaglia;Carlos Chouza;Erik Dupont

  • Motor-language coupling: direct evidence from early Parkinson's disease and intracranial cortical recordings.

    Agustín Ibáñez;Agustín Ibáñez;Agustín Ibáñez;Juan F. Cardona;Juan F. Cardona;Juan F. Cardona;Yamil Vidal Dos Santos;Yamil Vidal Dos Santos;Alejandro Blenkmann

  • Action-verb processing in Parkinson’s disease: new pathways for motor–language coupling

    Juan Felipe Cardona;Oscar Gershanik;Oscar Gershanik;Carlos Gelormini-Lezama;Carlos Gelormini-Lezama;Alexander Lee Houck

  • Cabergoline in the treatment of early parkinson's disease: Results of the first year of treatment in a double-blind comparison of cabergoline and levodopa

    U. K. Rinne;F. Bracco;C. Chouza;E. Dupont

  • Six Action Steps to Address Global Disparities in Parkinson Disease: A World Health Organization Priority.

    Unknown

  • Impairments in social cognition in early medicated and unmedicated Parkinson disease.

    María Roca;Teresa Torralva;Ezequiel Gleichgerrcht;Anabel Chade

  • Levodopa in the treatment of Parkinson's disease: a consensus meeting.

    Y. Agid;E. Ahlskog;A. Albanese;D. Calne

  • Assessing the non-motor symptoms of Parkinson's disease: MDS-UPDRS and NMS Scale

    P. Martinez-Martin;K. R. Chaudhuri;J. M. Rojo-Abuin;C. Rodriguez-Blazquez

  • Neuropsychological disturbances in hemiparkinson's disease

    Sergio Starkstein;Ramon Leiguarda;Oscar Gershanik;Marcelo Berthier

  • Polysomnographic measures in Parkinson's disease: a comparison between patients with and without REM sleep disturbances.

    T C Wetter;C Trenkwalder;O Gershanik;B Högl

  • A clinical, pharmacologic, and polysomnographic study of sleep benefit in Parkinson's disease

    B E Högl;G Gómez-Arévalo;S García;O Scipioni

  • Treatable inherited rare movement disorders

    H. A. Jinnah;Alberto Albanese;Kailash P. Bhatia;Francisco Cardoso

  • How embodied is action language? Neurological evidence from motor diseases

    Juan F. Cardona;Juan F. Cardona;Juan F. Cardona;Lucila Kargieman;Lucila Kargieman;Vladimiro Sinay;Oscar Gershanik;Oscar Gershanik

Frequent Co-Authors

Facundo Manes
Facundo Manes Favaloro University
Agustín Ibáñez
Agustín Ibáñez Adolfo Ibáñez University
Marcelo Rubinstein
Marcelo Rubinstein University of Buenos Aires
Rita Raisman-Vozari
Rita Raisman-Vozari Université Paris Cité
Birgit Högl
Birgit Högl Innsbruck Medical University
Werner Poewe
Werner Poewe Innsbruck Medical University
Yves Agid
Yves Agid Institut du Cerveau
Adolfo M. García
Adolfo M. García University of San Andrés
Sandra Baez
Sandra Baez Universidad de Los Andes
Teresa Torralva
Teresa Torralva Instituto de Neurología Cognitiva

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

As you explore studying Neuroscience in the USA, it’s worth considering a variety of online degrees and career pathways that can complement or enhance your expertise. For students seeking flexibility, accelerated online degrees offer a fast-track route to earning your credentials, letting you graduate and enter the workforce sooner without sacrificing academic rigor.

Neuroscience majors often intersect with high-demand fields. According to data on the highest earning degrees and the most lucrative college degrees, areas such as biomedical engineering, information technology, and health sciences can open doors to rewarding careers and higher earning potential.

Cost is another key factor. Many online colleges that accept financial aid can help reduce your financial burden, making advanced education more accessible. No matter your path, explore programs that align with your personal goals, budget, and long-term career aspirations.

Best Scientists Citing Oscar S. Gershanik

Trending Scientists

Recently Published Articles